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Objective:  To investigate  the  relationship  between  TXNIP  polymorphisms,  diabetes  and  hypertension
phenotypes  in the Brazilian  general  population.
Methods: Five  hundred  seventy-six  individuals  randomly  selected  from  the general  urban  population
according  to the  MONICA-WHO  project  guidelines  were  phenotyped  for cardiovascular  risk factors.  A
second,  independent,  sample  composed  of 487 family-trios  from  a  different  site was  also  selected.  Nine
TXNIP  polymorphisms  were  studied.  The  potential  association  between  TXNIP  variability  and  glucose-
phenotypes  in  children  was  also  explored.  TXNIP  expression  was quantiﬁed  by real-time  PCR in  53
samples  from  human  smooth  muscle  cells  primary  culture.
Results: TXNIP  rs7211  and  rs7212  polymorphisms  were  signiﬁcantly  associated  with  glucose  and  blood
pressure  related  phenotypes.  In multivariate  logistic  regression  models  the  studied  markers  remained
associated  with  diabetes  even  after  adjustment  for covariates.  TXNIP  rs7211  T/rs7212 G  haplotype
(present  in  approximately  17%  of individuals)  was  signiﬁcantly  associated  to diabetes  in  both  samples.
In  children,  the  TXNIP  rs7211  T/rs7212  G haplotype  was  associated  with  fasting  insulin concentrations.
Finally,  cells  harboring  TXNIP  rs7212  G allele  presented  higher  TXNIP  expression  levels  compared  with
carriers  of  TXNIP  rs7212  CC  genotype  (p  =  0.02).
Conclusion: Carriers  of TXNIP  genetic  variants  presented  higher  TXNIP  expression,  early  signs of  glucose
homeostasis  derangement  and  increased  susceptibility  to chronic  metabolic  conditions  such  as  diabetes
and  hypertension.  Our  data  suggest  that genetic  variation  in the  TXNIP  gene  may  act as  a  “common
ground”  modulator  of both  traits:  diabetes  and  hypertension.. Background
Diabetes and hypertension are growing global health problems.
oth conditions have a complex etiology involving the inter-
ction between genetic and environment factors, such as diet,
besity, oxidative stress, and sedentarism [1,2]. Diabetes incidence
ncreases rapidly worldwide probably due to the explosive increase
n obesity over the last decade [2]. Individuals with previously
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undiagnosed diabetes have an unfavorable cardiovascular risk pro-
ﬁle compared with glucose tolerant individuals [3–5]. Several
studies have been performed with the aim of identifying candi-
date loci in pathways implicated both in glucose and blood pressure
homeostasis [4,6–8].
The  TXNIP protein (thioredoxin interacting protein) was  ﬁrst
isolated from a 1,25-dihydroxyvitamin D3-treated HL-60 human
promyelocytic cell line and therefore called vitamin D3-up-
regulated gene 1 (vdup) [9]. This protein inhibits the thioredoxin
(TXN) system functioning as an endogenous inhibitor [10]. TXN is
a multifunctional antioxidant enzyme expressed in various tissues
[11] and plays an indirect, but essential, role in signaling molecules
Open access under the Elsevier OA license.by protein–protein interactions [12].
To date, TXNIP gene has been identiﬁed as one of the most dra-
matically up-regulated genes in studies looking at the genomic
effect of glucose on isolated islet cells [13]. TXNIP is over-expressed
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n diabetes and has deleterious effects on pancreatic  cells.
n addition, TXNIP affected INS-1  cell gene expression and
XNIP over-expression impairs glucose induced insulin secretion
nd it has been hypothesized that the TXNIP gene represents a
ink between glucose-toxicity and  cell apoptosis, two  critical
echanisms in the pathogenesis of diabetes [14]. In addition,
t appears that TXNIP is also modulated by mechanical stimuli
rom the cardiovascular system, as occurs during pressure-
verload cardiac hypertrophy or even physiologic ﬂuid shear stress
15].
Here, the main aim was to investigate the relationship between
XNIP genetic variation and diabetes and hypertension phenotypes
n a large sample from an ethnically mixed Brazilian population. In
ddition, through replication studies and ex vivo gene expression
xperiments we aimed at identifying the potential molecular link
etween TXNIP polymorphisms and diabetes and hypertension.
. Methods
.1. Study samples
.1.1. Derivation sample
A cross-sectional study of risk factors for cardiovascular diseases
as performed in the urban population of Vitoria, Espirito Santo
tate, Brazil, using the WHO-MONICA project guidelines [16]. A
ample of 2044 individuals (from an eligible population of 137,330)
f either gender, 25–64 years old, was chosen according to the near-
st birthday after a random selection of domiciles. Ethnicity was
ategorized as Caucasian-descents, African-descents and racially
ixed individuals [17]. In present analysis, data from 576 partici-
ants were used. Physical examination emphasized measurement
f height, weight, smoking habits, and alcohol consumption.
Blood pressure was measured using a standard mercury
phygmomanometer on the left arm after 5 min  rest, in the sit-
ing position. Systolic (SBP) and diastolic (DBP) blood pressures
ere calculated from three readings with a minimal interval
f 5 min. Hypertension was deﬁned as SBP ≥ 140 mmHg  and/or
BP ≥ 90 mmHg  and/or use of anti-hypertension drugs [18].
Blood glucose, total cholesterol, lipoprotein fractions, and
riglycerides were assayed by standard techniques in 12-h fasting
lood sample. Diabetes mellitus was deﬁned as a fasting glu-
ose ≥ 126 mg/dL and/or use of hypoglycemic drugs. No participant
eported presence of type 1 diabetes mellitus. Body mass index
BMI) (weight in kg/height in meters [2]) was calculated. Height
as measured in centimeters and weight in kilograms using a cal-
brated balance. Supine waist girth was measured at the umbilicus
evel [19].
.1.2. Replication sample
The Itapetininga study population comprised 487 family-trios.
ach trio was composed of 1 child and at least 1 parent (total 865
arents). Children, 2–18 years old, were randomly selected from the
9 public schools in the Itapetininga City, Sao Paulo State, Brazil,
fter informed consent was obtained from the parents. Ethnicity
self-referred) information for this sample was used in the present
nalysis for model adjustment similarly as in the derivation sample.
ardiovascular risk factors were evaluated by a standard ques-
ionnaire directed to both the child and the parents along with a
etailed medical examination. Blood pressure was measured using
ppropriate cuffs for arm length on mercury sphygmomanome-
ers with the subject in a sitting position after a 5-min rest. Blood
amples were collected after a 12-h fast. Total cholesterol, lipopro-
ein fractions, triglycerides, and blood glucose were determined by
tandard enzymatic methods. High sensitivity assay for C-reactive
rotein was performed by immunochemistry (Cardiophase®, Dadeosis 221 (2012) 131– 136
Behring, MA,  USA). Insulin was determined by electrochemilumi-
nescence (Roche Diagnostics, Mannheim, Germany).
In the present analysis, data from the 865 parents were used as a
replication sample. Data from the children plus parents in a family-
based association study design were used for dissecting potential
early effects of the observed risk genotypes on glucose homeostasis
on children.
2.2. Assessment of genotypes for the TXNIP gene polymorphism
Nine TXNIP polymorphisms (rs833392, rs2791749, rs2791750,
rs6674773, rs7548422, rs7211, rs7212, rs4755, and rs13203)
were selected as representative of the genetic variation
at this locus using information available from the HapMap
Project homepage (www.hapmap.org) and the dbSNP database
(www.ncbi.nlm.nih.gov). However, only TXNIP rs833392, rs7211,
rs7212, and rs4755 were signiﬁcantly polymorphic in our sample
to be used in the analysis.
Genomic DNA was extracted from peripheral blood leukocytes
by means of a salting-out procedure. Table 1 in the Supplemen-
tary appendix shows primers and restriction endonucleases used
in the PCR-RFLP (polymerase chain reaction-restriction fragment
length polymorphism assay). A 30-cycle PCR was  carried out using a
10 L reactive solution containing (10 mM Tris–HCl, pH 9.0; 50 mM
KCl; 2.5 mM MgCl2; 100 M of each dNTP; 0.3 U Taq DNA poly-
merase; 5 pmol of each primer; 50 ng of genomic DNA template).
PCR products were digested with 1 U of the appropriate restriction
enzyme and visualized by 3% agarose gel electrophoresis. Quality
control for these assays was  assessed by randomly selecting 40
samples for re-genotyping. One-hundred percent concordance was
observed in these tests.
2.3. Vessel harvesting and primary culture of smooth muscle cells
(SMC)
Human mammary artery (h-MA) segments were obtained from
patients undergoing aortocoronary bypass surgery at the Heart
Institute (InCor), University of Sao Paulo Medical School. All
individuals gave informed consent to participate in the study,
which was  reviewed and approved by the local Ethics Commit-
tee (SDC 2454/04/074-CAPPesq 638/04). Cells were obtained by
explant protocol and cultured with Dulbecco’s modiﬁed Eagle’s
medium containing 20% fetal bovine serum, 100 U/mL penicillin,
100 g/mL streptomycin. Primary culture cells were expanded
until the third passage, when total RNA was  extracted for gene
expression quantiﬁcation. Smooth muscle cells were character-
ized by hill-and-valley growth pattern and by immunoﬂuorescence
staining for -smooth muscle actin [20].
2.4. Gene expression by real Time reverse transcription
polymerase chain reaction (RT-PCR)
Quantitative RT-PCR was  performed in h-MA primary culture
cells. Total RNA was  isolated with Trizol LS Reagent® according
to the manufacturer’s instructions (Invitrogen Corp., Carlsbad, CA,
USA) and cDNA synthesis was performed with random hexamers
(High Capacity cDNA Archive®; kit-PE Applied Biosystems, Foster
City, CA, USA). Five nanograms of cDNA were used for real-time
reaction by SYBR® Green PCR Master Mix-PE – ABI Prism 7500 Fast
System® (Applied Biosystem, Foster City, CA, USA). All samples were
assayed in triplicate and 28S ribosomal and cyclophilin gene RNA
were used as an internal control to normalize the results. Efﬁ-
ciencies of TXNIP and 28S and cyclophilin ampliﬁcation reactions
were very similar and close to 1. Comparative threshold (CT) cycle
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Table 1
Demographic and biochemical data of the studied populations.
Derivation
sample Vitoria
Replication sample
Itapetininga
p Value
Total sample 576 865
Gender (female),
%
59.9 52.5 0.005
Diabetes, % 9.0 3.6 <0.001
Hypertension, % 37.0 10.6 <0.001
Age, years 44.5 ± 11.0 39.8 ± 8.0 <0.001
Glucose, mg/dL 105.5 ± 32.8 91.5 ± 29.4 <0.001
Triglycerides,
mg/dL
133.0 ± 94.3 146.0 ± 102.5 <0.001
Total cholesterol,
mg/dL
219.0 ± 44.8 197.4 ± 42.2 <0.001
HDL cholesterol,
mg/dL
45.0 ± 11.6 44.4 ± 12.2 0.193
LDL  chelesterol, 148.0 ± 40.9 124.1 ± 37.0 <0.001
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Table 2
Relationship between TXNIP polymorphisms and glucose and blood pressure.
Alleles Glucose (mg/dL) SBP (mmHg) DBP (mmHg)
Derivation sample Vitoria
rs7211 C 108.6 ± 2.1 129.0 ± 1.4 84.3 ± 0.8
rs7211 T 114.6 ± 3.6 132.1 ± 2.3 85.9 ± 1.4
p values 0.005/0.05 0.03/0.34 0.05/0.45
rs7212 C 107.5 ± 2.4 129.6 ± 1.6 84.8 ± 0.9
rs7212 G 110.7 ± 4.2 133.1 ± 2.7 86.9 ± 1.6
p values 0.18/0.63 0.03/0.29 0.02/0.25
rs4755 A 105.8 ± 2.4 129.8 ± 1.5 85.3 ± 0.9
rs4755 T 106.5 ± 4.0 134.1 ± 2.6 87.4 ± 1.5
p values 0.77/0.68 0.05/0.03 0.005/0.04
Replication sample Itapetininga
rs7211 C 90.7 ± 1.8 122.1 ± 1.5 78.3 ± 1.0
rs7211 T 91.2 ± 2.9 124.0 ± 2.4 79.6 ± 1.6
p values 0.78/0.90 0.14/0.37 0.17/0.39
rs7212 C 92.3 ± 1.9 122.0 ± 1.5 78.3 ± 1.0
rs7212 G 93.5 ± 3.3 123.9 ± 2.7 79.5 ± 1.8
p values 0.51/0.40 0.21/0.33 0.24/0.42
rs4755 A 91.4 ± 1.9 123.5 ± 2.8 78.3 ± 1.2
rs4755 T 91.8 ± 3.5 126.0 ± 3.2 78.9 ± 1.3
p values 0.78/0.13 0.08/0.35 0.75/0.75
Number of alleles for the rs7211 (887 vs 265 and 1384 vs 346), rs7212 (946 vs 206
and 1453 vs 277), rs4755 (899 vs 253 and 1073 vs 657), in the Vitoria and Itapetininga
samples, respectively. These analysis were performed for BMI, total cholesterol and
triglycerides, but no signiﬁcant difference was observed according to TXNIP alleles.
TXNIP rs833392 alleles did not demonstrate association with the analyzed variables.
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure.mg/dL
DL: high-density lipoprotein; LDL: low-density lipoprotein.
ethod was used for data analyses. CT is the difference in thresh-
ld cycle for target (TXNIP) and reference (28S and cyclophilin).
.5. Statistical analysis
Kolmogorov–Smirnov and Shapiro–Wilk tests were used for
ssessing sample distribution. Continuous variables were com-
ared using one-way ANOVA (analysis of variance) and presented
s mean ± SD (standard deviation). Categorical variables were
ompared using Chi-square test and presented as percentage. Mul-
ivariate linear regression models were created for adjustment for
otential confounding variables. Logistic regression analysis was
arried out to estimate the odds ratio (OR), in order to assess
enetic risk factors for diabetes and hypertension according to
XNIP polymorphisms. Biochemical data, blood pressures, diabetes
nd hypertension phenotypes were adjusted for age, gender and
MI. In the Vitoria sample ethnicity was available and logistic
egression models were also adjusted for this confounder. Ethnicity
as entered into the model as dummy  variables (0/1 for Caucasian
thnicity and 0/1 for Mulatto ethnicity).
Gene expression was  presented as mean 2−CT plus standard
eviations and differences among TXNIP groups were analyzed
sing the Students t-test by comparing differences in the mean lev-
ls of each genotype. Statistical analyses were carried out using the
PSS 16.0 software, with the level of signiﬁcance set at p < 0.05.
Hardy–Weinberg equilibrium, linkage disequilibrium (LD), and
aplotypic association analysis were conducted with Haploview
.0 software [21]. Quantitative transmission disequilibrium test
QTDT) software package was used for linkage and LD studies on the
amily-trios structure data. Analysis using allele and haplotype data
or continuous traits were conducted using the HAPSTAT Program.
. Results
.1. Demographic and genetic structure data
Demographic data of the studied population samples are shown
n Table 1. Allelic, genotypic and haplotypic data are presented in
able 2 in the Supplementary appendix.
All studied TXNIP polymorphisms were in accordance with
he Hardy–Weinberg equilibrium. Pairwise linkage disequilib-
ium (LD) analysis has shown signiﬁcant disequilibrium between
he TXNIP rs833392, rs7211, and rs7212 (Fig. 1 in the Supple-
entary appendix).  TXNIP rs4755 had no strong disequilibrium
ith other markers assayed in the TXNIP gene (Fig. 1 in the
upplementary appendix).Data shown as mean ± standard error for univariate (unadjusted analysis). Provided
p  values are for unadjusted and adjusted (age, gender, BMI  and ethnicity) analysis,
respectively.
In further analysis, the two polymorphisms with higher LD
(rs7211 and rs7212) were used for haplotype-based analysis. All
tested polymorphisms were also analyzed as one block, but results
based on haplotypes deﬁned by SNPs rs7211 and rs7212 presented
best ﬁt compared to association analyzes using haplotypes deﬁned
by all 4 polymorphisms. In addition, low haplotypic diversity was
observed in this locus. Only 3 different haplotypes could explain
more than 90% of the overall genetic diversity of this locus in the
studied sample (Table 2 in the Supplementary appendix).
3.2. Relationship between TXNIP alleles and blood glucose and
blood pressure
Comparisons for each genetic variant were performed using p-
values unadjusted and adjusted for age, gender, BMI, and ethnicity
(Table 2). In the Vitoria sample, after univariate analysis, association
was disclosed between TXNIP rs7211 and blood glucose concentra-
tions (p = 0.005) and both SBP and DBP (p = 0.03); and for TXNIP
rs7212 and TXNIP rs4755 for SBP (p = 0.03 and p = 0.03) and DBP
(p = 0.05 and p = 0.02), respectively (Table 2, p-values for unadjusted
analysis).
In the Vitoria sample, TXNIP rs7211 T allele persisted signiﬁ-
cantly associated with glucose concentrations after adjustment for
age, gender, BMI, and ethnicity (p = 0.052).
In the replication sample, the TXNIP rs7211 did not present asso-
ciation with glucose concentrations, SBP and DBP (Table 2).
No relationship between TXNIP polymorphism alleles and total
cholesterol, lipoprotein fractions, triglycerides and BMI  was found
(data not shown).
3.3. Relationship between TXNIP alleles, diabetes and
hypertension phenotypes
TXNIP rs7212 G allele frequencies in diabetic and non-diabetic
individuals were signiﬁcantly different and replicated in both
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Table 3
Relationship between TXNIP haplotypes and glucose and blood pressure.
Haplotypes Glucose (mg/dL) SBP (mmHg) DBP (mmHg)
Derivation sample
Vitoria
n = 576 n = 576 n = 576
rs7211 C/rs7212 C 109.8 ± 5.3 (vs 114.1) 128.7 ± 3.8 84.2 ± 2.2
p  values 0.007/0.06 0.04/0.41 0.06/0.46
rs7211 T/rs7212 C 115.9 ± 5.1 (vs 104.1) 127.7 ± 3.7 83.1 ± 2.2
p  values 0.005/0.009 0.88/0.79 0.79/0.57
rs7211 T/rs7212 G 107.7 ± 4.1 129.7 ± 2.7 84.7 ± 1.6
p  values 0.14/0.55 0.02/0.23 0.02/0.24
Haplotypes Glucose (mg/dL) SBP (mmHg) DBP (mmHg)
Replication sample
Itapetininga
n = 804 n = 498 n = 500
rs7211 C/rs7212 C 91.2 ± 4.6 121.8 ± 3.8 78.2 ± 2.8
p  Values 0.74/0.86 0.15/0.37 0.18/0.35
rs7211 T/rs7212 C 87.3 ± 4.5 121.6 ± 4.2 78.6 ± 2.8
p  Values 0.06/0.06 0.64/0.91 0.65/0.92
rs7211 T/rs7212 G 92.4 ± 4.4 122.9 ± 2.8 78.1 ± 1.9
p  Values 0.47/0.37 0.20/0.38 0.23/0.33
These analysis were performed for BMI, total cholesterol and triglycerides, but no
signiﬁcant difference was observed according to TXNIP haplotypes. BMI: body mass
index; SBP: systolic blood pressure; DBP: diastolic blood pressure. Data shown as
mean ± standard error for univariate (unadjusted analysis). Provided p values are
for  unadjusted and adjusted (age, gender, BMI  and ethnicity) analysis, respectively.
Lower case values represent estimated unadjusted mean values for all other haplo-
types.
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a tendency toward increased expression levels in individuals har-amples in models adjusted for age, gender, BMI, and ethnic-
ty (p value for unadjusted and adjusted analysis in derivation
ample = 0.001 and 0.04, respectively; p value for unadjusted
nd adjusted analysis in replication sample = 0.04 and 0.04,
espectively). Higher diabetes odds in both population sam-
les were associated with rs7212 G allele (OR, 2.50; 95%
I, 1.30–4.60 and OR, 1.85; 95% CI, 1.02–3.33) (p = 0.006
nd p = 0.025, respectively for the derivation and replication
amples).
The TXNIP rs7211 T allele was also associated with hypertension
OR, 2.26; p = 0.005 and OR, 2.42; p = 0.001) for both Vitoria and
tapetininga samples, even after adjustment for covariates.
In the Vitoria sample, presence of at least one T allele of
he rs7211 marker was associated with diabetes (OR, 2.78;
5% CI, 1.40–5.50). Likewise, presence of at least one G
llele of the rs7212 marker was also associated with diabetes
OR, 2.36; 95% CI, 1.22–4.59). For hypertension, both mark-
rs were not signiﬁcant anymore after the adjustment for
thnicity.
.4. Relationship between TXNIP haplotypes and blood glucose
nd blood pressure
LD for all possible two-way comparison among the 4 selected
XNIP polymorphisms was investigated.
In the Vitoria sample, lower and higher mean values of blood
lucose were observed in the TXNIP rs7211 C/rs7212 C and rs7211
/rs7212 C haplotype groups (p = 0.005 and p = 0.009, respec-
ively), compared with other haplotype groups (Table 3). This
as true even after adjustment for age, gender, BMI, and ethnic-
ty (Table 3). This was not replicated in the replication sample
Table 3).No relationship between TXNIP haplotypes and total cholesterol,
ipoprotein fractions, triglycerides and BMI  was found.Fig. 1. Prediction curves of insulin level taken into consideration haplotype status
and participant age.
3.5. Relationship between TXNIP haplotypes and diabetes and
hypertension phenotypes
In an unadjusted model, the presence of TXNIP rs7211 T/rs7212
G haplotype was  associated with diabetes in both Vitoria and Itape-
tininga samples, respectively (Table 4).
Haplotype analysis adjusting for age, gender, BMI, and ethnicity
were concordant and showed a signiﬁcantly higher frequency of
diabetes in individuals harboring the rs7211 T/rs7212 G haplotype
in both Vitoria (p = 0.05) and Itapetininga (p = 0.03) samples.
3.6. TXNIP genetic variants and glucose homeostasis in children
Haplotype analyses for several variables associated with glucose
homeostasis were conducted (Table 2, Supplementary appendix).
Children carrying TXNIP rs7211 T/rs7212 G haplotype were associ-
ated with higher blood insulin values (3.85 UI/mL) compared with
other haplotype groups (2.76 UI/mL), even after adjustment for
age and age *genotype interaction (p = 0.032). Of particular impor-
tance is the fact that one should analyze these results taken into
account the fact that the interaction term of this model was also
statistically signiﬁcant. This makes it difﬁcult to interpret the sole
genotype effect since it depends on the participant age (Fig. 1).
Nonetheless, this analysis suggests that for the identiﬁed risk hap-
lotype carriers increased insulin levels are predicted as one grows
older. This information is important in our formulating model to
explain the effect of TXNIP genetic variability and diabetes (see
Fig. 1 and Section 4).
A computer-model was performed to predict the homeo-
static concentrations which arise from varying degrees of -cell
deﬁciency and insulin resistance (HOMA – homeostasis model
assessment) [22]. The effect of TXNIP rs7211 T/rs7212 G haplotype
on children was  not observed for these phenotypes (Table 2, Sup-
plementary appendix).
3.7. TXNIP gene expression
An RT-PCR assay was developed to characterize TXNIP mRNA
expression in smooth muscle cells. Cells from 53 individuals were
used. From these, 42 had the rs7212 CC genotype, and 11 had the
rs7212 CG genotype.
Cells carrying TXNIP rs7212 CG had higher TXNIP expression
(mean 2−CT , 0.18; s.d., 0.10) compared with carriers TXNIP rs7212
CC (mean 2−CT , 0.10; s.d., 0.08) (p = 0.01). No association between
TXNIP gene expression and rs7211 genotypes was  observed, butboring the T allele was  also observed (CC (n = 43) mean 2−CT , 0.10;
s.d., 0.08 and CT (n = 10) mean 2−CT , 0.14; s.d., 0.09).
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Table 4
Analysis of diabetes and hypertension association with case-control TXNIP haplotype frequencies.
Diabetes Hypertension
Case Control p value Adjusted p value Case Control p value Adjusted p value
Derivation sample
rs7211 C/rs7212 C 0.62 0.78
0.006 0.05
0.74 0.78
0.13 0.65
rs7211 T/rs7212 C 0.00 0.00 0.00 0.00
rs7211 C/rs7212G 0.09 0.05 0.06 0.05
rs7211 T/rs7212G 0.28 0.17 0.20 0.16
Replication sample
rs7211 C/rs7212 C 0.72 0.78
0.04 0.03
0.71 0.79
0.02 0.10
rs7211 T/rs7212 C 0.00 0.00 0.00 0.00
rs7211 C/rs7212G 0.00 0.05 0.05 0.04
rs7211 T/rs7212G 0.28 0.17 0.24 0.16
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ample: 52, number of diabetic controls derivation sample: 524. Diabetic cases rep
ases  derivation sample: 203, hypertension controls derivation sample: 373. Hyper
. Discussion
Signiﬁcant relationship between TXNIP genetic variation and
iabetes and hypertension were observed in two general samples
rom the general population, Itapetininga and Vitoria. In addi-
ion, blood glucose, SBP and DBP, as continuous variables, were
ssociated to TXNIP markers. Interestingly, multivariate logistic
egression models were able to demonstrate the association of
he studied markers with diabetes, even after adjustment for their
nown covariates (age, gender and BMI) plus ethnicity. Finally, we
ere also able to observe derangements in glucose homeostasis
ssociated with the identiﬁed risk haplotype in children.
TXNIP protein is an endogenous inhibitor of thioredoxin, and
lays a pivotal role in several important processes of cardiovascular
omeostasis by functioning as a biological sensor for biomechanical
nd oxidative stress [12]. It appears that TXNIP is also modulated
y mechanical stimuli from the cardiovascular system, as occurs
uring pressure-overload cardiac hypertrophy or even physiologic
uid shear stress [15].
Few studies to date have aimed at investigating the possible
ole of TXNIP genetic variation on cardiovascular phenotypes. Coon
t al., using a subset of families from the NHLBI Family Heart
tudy, researched the impact of TXNIP genetic variation on lipid
nd serum glucose concentrations, but they did not ﬁnd any asso-
iation with the studied phenotypes [23]. Nevertheless, they did
ot study rs7211 and rs7212, our two associated markers. It is pos-
ible that the previously used markers were not able of capturing
 signiﬁcant amount of this locus overall variability, limiting the
tatistical power of their approach. van Greevenbroek et al. using
etabolic data investigated whether TXNIP polymorphisms deter-
ine an effect on parameters associated with lipid and glucose
etabolism in humans [24]. Plasma triglycerides concentrations
ere higher in diabetic individuals carrying TXNIP rs7211 T allele
han diabetics with the common C allele [24]. The authors con-
luded that effect of TXNIP on triglycerides is inﬂuenced by plasma
lucose concentrations, suggesting that the biological relevance of
XNIP variation may  be particularly relevant in recurrent episodes
f hyperglycemia [24]. Our study did not ﬁnd any association with
riglycerides in diabetic individuals, but one should note that our
educed number of diabetic individuals might have reduced our
ensitivity to detect such association.
Parikh et al. combined genome-wide expression proﬁling,
enetic association testing and cellular studies to spotlight TXNIP
rotein as a physiologic regulator of peripheral glucose uptake in
umans [25]. Despite studying a sample of 4450 Scandinavian indi-
iduals, they did not found any signiﬁcant association between
XNIP tag SNPs, and diabetes or quantitative phenotypes, as fasting
lucose, insulin and HOMA  [25]. Nonetheless neither rs7211 nor
s7212 were part of their tag SNP list.latto yes/no). Number of individuals in each subgroup: diabetic cases derivation
n sample: 29, number of diabetic controls replication sample: 775. Hypertension
n cases replication sample: 94, hypertension controls derivation sample: 406.
The TXNIP rs7211 T/rs7212 G haplotype (present in approx-
imately 17% of Brazilian individuals) has consistently shown to
be associated with diabetes in both population samples: Vitoria
and Itapetininga (OR, 1.94; 95% CI, 1.23–3.07 and OR, 1.89; 95% CI,
1.04–3.41, respectively). TXNIP was over-expressed in h-MA of the
individuals with TXNIP rs7212 CG group compared with CC group.
Finally, in children, insulin concentrations were higher in carriers of
TXNIP rs7211 T/rs7212 G haplotype. This dependence was mainly
observed in older children, suggesting that the age *genotype rela-
tionship may  be increasing the risk of glucose derangements as the
individual gets older.
A TXNIP-diabetes pathogenic hypothesis suggested by our
group, based on published data, was  that TXNIP regulates both
insulin-dependent and insulin-independent pathways of glucose
uptake [26]. TXNIP protein is an endogenous inhibitor of thiore-
doxin enzyme expressed in vessels, which is a gateway of cell
damage. Thioredoxin is a key component of redox regulation
and has been indicated to play an essential role in cell survival
and growth [27]. TXNIP expression was inversely correlated with
insulin-stimulated glucose uptake and that TXNIP expression was
elevated by glucose in human muscle cells [25]. It is known
that hyperglycemia induced oxidative stress modulated by TXNIP
induction, with the consequent inhibition of the anti-oxidative
function [28]. In addition, TXNIP is dramatically induced by glucose
[27] and, in hyperglycemia, inhibits thioredoxin with accompany-
ing impairment in vascular network formation [27,29].
Taken together, one could formulate a model in which TXNIP
genetic variation may  modulate both diabetes and vascular risk
as follows: TXNIP increased expression (associated with the TXNIP
rs7211 T/rs7212 G haplotype) decreases glucose uptake in mus-
cle cells and thereby increases the concentrations of circulating
insulin and glucose, explaining the data observed in both children
and adults. The increased glucose in the pancreas leads to glucose-
toxicity causing a progressive reduction of  cell secretion. The net
result is hyperglycemia. In the hyperglycemic status, individuals
with TXNIP rs7211 T/rs7212 G haplotypes are more susceptible to
have altered gene expression in the pancreas resulting in an even
greater loss of the mass of  cells by apoptosis induced by the TXNIP
protein.
Our study has some limitations. First, there were no replications
for the differences in glucose and blood pressures as continuous
variables. A possible explanation can be the signiﬁcant different
mean age between the Vitoria and Itapetininga population sam-
ples. Nonetheless, association between diabetes and hypertension
according to TXNIP polymorphisms was replicated in both pop-
ulation samples, even with a lower frequency of diabetes and
hypertension cases in the Itapetininga subjects. Second, despite the
positive results and the replication of the results for dichotomous
traits, especially diabetes, we  have worked with a small number
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f diabetic individuals. In order to reduce the concern of false pos-
tive results one should take into consideration that several lines
f evidence point toward the conclusion of the observed associa-
ion: replication in both samples, replication with an intermediate
henotype in children and evidence of the association with gene
xpression levels in ex vivo experiments. Finally, we  were not able
o speciﬁcally determine the molecular alteration responsible for
he observed association. It is tempting, however, to suggest that
enetic variation in the 3′ portion of TXNIP RNA is responsible for
he differential gene expression observed. In fact, both rs7211 and
s7212 are located in the 3′ region and may  be susceptible to dif-
erent gene expression regulating mechanisms (i.e., modulate RNA
tability, microRNA binding, etc.).
Nonetheless, in the described scenario, our data plus litera-
ure data provide evidence that the TXNIP gene may  constitute not
nly a gateway for biomechanical transduction in the cardiovas-
ular system, but may  also be a fundamental link between both
pidemiological and mechanistic studies involving diabetes and
ypertension.
To the best of our knowledge, this was the ﬁrst study analyzing
XNIP polymorphisms and diabetes and hypertension phenotypes
n both derivation and replication population samples. These
enetic associations, although exploratory regarding casual rela-
ions, may  have a role in the generation of hypothesis to be tested
n more controlled studies.
In conclusion, individuals harboring speciﬁc TXNIP genetic con-
titution present higher levels of TXNIP expression, early signs of
lucose homeostasis derangement and increased susceptibility to
hronic metabolic conditions such as diabetes and hypertension.
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